本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Agios Pharmaceuticals, Inc.

32.81
-0.4100-1.23%
盤後32.810.00000.00%19:30 EDT
成交量:135.40萬
成交額:4,448.40萬
市值:19.51億
市盈率:-4.68
高:33.48
開:33.23
低:32.22
收:33.22
52周最高:46.00
52周最低:22.24
股本:5,947.16萬
流通股本:5,008.85萬
量比:1.65
換手率:2.70%
股息:- -
股息率:- -
每股收益(TTM):-7.0075
每股收益(LYR):-7.1203
淨資產收益率:-34.34%
總資產收益率:-22.24%
市淨率:1.90
市盈率(LYR):-4.61

資料載入中...

2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/03

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/02

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/18

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/29

重要事件披露

Form 8-K - Current report
2026/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities